Stephens Inc’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,390
Closed -$254K 1412
2021
Q2
$254K Buy
9,390
+376
+4% +$10.5K ﹤0.01% 1112
2021
Q1
$270K Sell
9,014
-2,449
-21% -$83.5K ﹤0.01% 1050
2020
Q4
$329K Sell
11,463
-2,494
-18% -$67.3K 0.01% 897
2020
Q3
$341K Sell
13,957
-5,060
-27% -$109K 0.01% 831
2020
Q2
$340K Buy
19,017
+4,327
+29% +$56.9K 0.01% 806
2020
Q1
$120K Sell
14,690
-300
-2% -$3.43K ﹤0.01% 960
2019
Q4
$198K Buy
+14,990
New +$181K ﹤0.01% 1010
2019
Q3
Sell
-4,752
Closed -$116K 1219
2019
Q2
$116K Buy
4,752
+3,178
+202% +$91.6K ﹤0.01% 1124
2019
Q1
$50K Buy
+1,574
New +$55.9K ﹤0.01% 1147

Other funds holding CVET

Stephens Inc's CVET Position: Q3 2021 in Review

Stephens Inc sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2021, closing a stake of 9,390 shares — an estimated $254K sold.

Stephens Inc first reported a position in CVET in Q1 2019 and held it in 9 quarters. The position peaked at $341K in Q3 2020. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

  • Stephens Inc reported no remaining Covetrus, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Stephens Inc sold 9,390 Covetrus, Inc. Common Stock shares in Q3 2021, an estimated $254K.
  • Stephens Inc first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
  • Stephens Inc's Covetrus, Inc. Common Stock position peaked at $341K in Q3 2020.
  • 260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on Stephens Inc's 13F filing for Q3 2021, filed 27 Oct 2021.